Xenomics Files Fraud Suit against Sequenom | GenomeWeb

NEW YORK (GenomeWeb News) – Xenomics today said that it has filed a lawsuit in New York State alleging Sequenom committed fraud in representing itself to Xenomics in a licensing deal inked last year.

In October 2008, Xenomics granted Sequenom exclusive global rights to use certain transrenal fetal nucleic acids in maternal urine for non-invasive prenatal diagnostics and analysis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."